AVITA Medical (RCEL) Operating Margin Growth (1y) (2019 - 2025)
AVITA Medical (RCEL) Operating Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 102.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -313.00 |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 851.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 241.00 |
| 10 | AVITA Medical | 133.70 Mn | 117.35 Mn | 14.31 Mn | 4,386.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,386.00 |
| Sep 30, 2025 | 1,646.00 |
| Jun 30, 2025 | 4,166.00 |
| Mar 31, 2025 | 9,041.00 |
| Dec 31, 2024 | 3,129.00 |
| Sep 30, 2024 | -243.00 |
| Jun 30, 2024 | -783.00 |
| Mar 31, 2024 | -6,101.00 |
| Dec 31, 2023 | 1,825.00 |
| Sep 30, 2023 | -498.00 |
| Mar 31, 2023 | 3,190.00 |
| Sep 30, 2022 | 58.00 |
| Mar 31, 2022 | -5,749.00 |
| Sep 30, 2021 | 13,806.00 |
| Jun 30, 2021 | 27,982.00 |
| Mar 31, 2021 | 32,902.00 |
| Dec 31, 2020 | 21,466.00 |
| Sep 30, 2020 | -8,930.00 |
| Jun 30, 2020 | -3,077.00 |
| Mar 31, 2020 | -678.00 |